Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.95 |
| ▸ | LMNA | P02545 | 2/20 | 0.95 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.54 |
| ▸ | APP | P05067 | 6/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.38 |
| ▸ | KDM6A | O15550 | 1/20 | 0.38 |
| ▸ | KDM4A | O75164 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KDM5C | P41229 | 1/20 | 0.38 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.38 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maltol SCHEMBL7087011 | 0.98 | KDM4E (0.91) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL4815 | 0.98 | — | — | |
| Maltol SCHEMBL901231 | 0.98 | KDM4E (1.00) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL8004441 | 0.95 | KDM4E (0.95) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL7710749 | 0.95 | KDM4E (0.95) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL23309785 | 0.95 | KDM4E (0.95) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL6912612 | 0.95 | KDM4E (0.95) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL8105208 | 0.95 | KDM4E (0.95) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL1866368 | 0.95 | KDM4E (0.95) | KDM4ELMNAALOX5APPMAPK1 | |
| Maltol SCHEMBL8619261 | 0.95 | KDM4E (0.95) | KDM4ELMNAALOX5APPMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12031152-B2 | Nutrient media for the production of slaughter-free meat | UPSIDE FOODS, INC. (US) | 2024-07-09 | — | — | US | claimed |
| CN-118206519-A | Preparation method of maltol iron crystal form V | 重庆药友制药有限责任公司 | 2024-06-18 | — | — | CN | claimed |
| EP-4370100-A1 | AMORPHOUS DISPERSION OF FERRIC MALTOL AND THE PREPARATION PROCESS THEREOF | Indena S.p.A. (IT) | 2024-05-22 | — | — | EP | claimed |
| WO-2024030855-A2 | SYSTEMS AND METHODS FOR TRANSDERMAL PATCH DELIVERY | VITAMAX PATCH WHOLESALER LLC (US) | 2024-02-08 | — | — | WO | claimed |
| CN-117310036-A | Method for measuring iron content in iron maltol by using derivatization high performance liquid chromatography | 江苏嘉逸医药有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117214363-A | Method for measuring maltol content in iron maltol bulk drug by high performance liquid chromatography | 江苏嘉逸医药有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-117092271-A | Method for measuring citric acid in ferric maltol by utilizing HILIC technology | 江苏嘉逸医药有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-114113066-B | Application of maltol iron peroxide mimic enzyme in detecting hydrogen peroxide and total antioxidant capacity | 西北农林科技大学 | 2023-09-29 | — | — | CN | claimed |
| CN-109790138-B | Method for producing iron maltol compositions from ligand-modified and ligand-coated iron hydroxide | 英国神盾TX股份有限公司 | 2023-08-18 | — | — | CN | claimed |
| WO-2023152710-A2 | NOVEL CRYSTALLINE FORMS OF IRON MALTOL COMPLEX AND PROCESS FOR THE PREPARATION | VIRUJ PHARMACEUTICAL PVT LTD (IN) | 2023-08-17 | — | — | WO | claimed |
| WO-2016066555-A1 | CRYSTALLINE FORMS OF FERRIC MALTOL | IRON THERAPEUTICS HOLDINGS AG (CH) | 2016-05-06 | — | — | WO | claimed |
| WO-2016041988-A1 | COMPOSITIONS AND METHODS FOR THE MAINTENANCE OF ADEQUATE IRON INTAKE IN A MAMMAL | ANABIO TECHNOLOGIES LIMITED (IE) | 2016-03-24 | — | — | WO | claimed |
| EP-2995205-A1 | Compositions and methods for the maintenance of adequate iron intake in a mammal | Anabio Technologies Limited (IE) | 2016-03-16 | — | — | EP | claimed |
| EP-1072198-B1 | Preparation for use as medicament and/or nutritional supplement | SWISS CAPS RECHTE & LIZENZEN (CH) | 2008-05-14 | — | — | EP | claimed |
| EP-0833627-B1 | IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF | VITRA PHARMACEUTICALS LTD (GB) | 2004-08-18 | — | — | EP | claimed |
| US-20030069218-A1 | Iron compounds, compositions , methods of making the same and uses thereof | IRON THERAPEUTICS HOLDINGS AG (CH) | 2003-04-10 | — | — | US | claimed |
| US-6368621-B1 | MIXTURE OF FOLIC ACID, IRON COMPLEX AND FATTY ACID | PETER GREITHER (CH) | 2002-04-09 | — | — | US | claimed |
| US-6339080-B1 | FOR THERAPY AND PROPHYLAXIS OF IRON DEFICIENCY DISORDERS INCLUDING IRON DEFICIENCY ANAEMIA | VITRA PHARMACEUTICALS LTD. (GB) | 2002-01-15 | — | — | US | claimed |
| EP-0833627-A2 | IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF | Vitra Pharmaceuticals Ltd. (GB) | 1998-04-08 | — | — | EP | claimed |
| WO-1996041627-A2 | IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF | VITRA PHARMACEUTICALS LTD (GB) | 1996-12-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069218-A1 | Iron compounds, compositions , methods of making the same and uses thereof | SDHB, HAMP, FTH1 | KDM4E 1951/4885LMNA 1694/4885ALOX5 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.